Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Semaphorin 3F forms an anti-angiogenic barrier in outer retina.
Buehler A, Sitaras N, Favret S, Bucher F, Berger S, Pielen A, Joyal JS, Juan AM, Martin G, Schlunck G, Agostini HT, Klagsbrun M, Smith LE, Sapieha P, Stahl A. Buehler A, et al. Among authors: bucher f. FEBS Lett. 2013 Jun 5;587(11):1650-5. doi: 10.1016/j.febslet.2013.04.008. Epub 2013 Apr 18. FEBS Lett. 2013. PMID: 23603393 Free PMC article.
Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations.
Koczorowska MM, Tholen S, Bucher F, Lutz L, Kizhakkedathu JN, De Wever O, Wellner UF, Biniossek ML, Stahl A, Lassmann S, Schilling O. Koczorowska MM, et al. Among authors: bucher f. Mol Oncol. 2016 Jan;10(1):40-58. doi: 10.1016/j.molonc.2015.08.001. Epub 2015 Aug 11. Mol Oncol. 2016. PMID: 26304112 Free PMC article.
Longitudinal Analysis of the Choriocapillaris Using Optical Coherence Tomography Angiography Reveals Subretinal Fluid as a Substantial Confounder in Patients with Acute Central Serous Chorioretinopathy.
Reich M, Böhringer D, Cakir B, Bucher F, Daniel M, Lang S, Lagrèze W, Agostini H, Lange C. Reich M, et al. Among authors: bucher f. Ophthalmol Ther. 2019 Dec;8(4):599-610. doi: 10.1007/s40123-019-00218-9. Epub 2019 Oct 25. Ophthalmol Ther. 2019. PMID: 31654333 Free PMC article.
Comparison of the Efficacy of Brolucizumab with Natural Disease Progression in Wet AMD Using Clinical Data from the Phase III HAWK and HARRIER Trials and Modelled Placebo Data.
Agostini H, Mulyukov Z, Tsilimbaris M, Calvo P, Bucher F, Gaucher D, Pigeolet E, Colafrancesco V, Clemens A. Agostini H, et al. Among authors: bucher f. Curr Eye Res. 2020 Oct;45(10):1298-1301. doi: 10.1080/02713683.2020.1731832. Epub 2020 Feb 26. Curr Eye Res. 2020. PMID: 32065533 Clinical Trial.
118 results